Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016

Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016


  • Products Id :- GDME0226EPD
  • |
  • Pages: 95
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, "Peripheral Transluminal Coronary Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016" provides an overview of Peripheral Transluminal Coronary Angioplasty Balloons currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Transluminal Coronary Angioplasty Balloons pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Peripheral Transluminal Coronary Angioplasty Balloons under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Peripheral Transluminal Coronary Angioplasty Balloons and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Peripheral Transluminal Coronary Angioplasty Balloons under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 7

2 Introduction 8

2.1 Peripheral Transluminal Coronary Angioplasty Balloons Overview 8

3 Products under Development 9

3.1 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9

3.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10

3.3 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11

3.4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12

3.5 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13

3.6 Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14

4 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products under Development by Companies 15

4.1 PTCA Balloons Companies - Pipeline Products by Stage of Development 15

4.2 Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17

5 Peripheral Transluminal Coronary Angioplasty Balloons Companies and Product Overview 19

5.1 Aachen Resonance GmbH Company Overview 19

5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

5.2 Acrostak (Schweiz) AG Company Overview 20

5.2.1 Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20

5.3 AlviMedica Medical Technologies Inc. Company Overview 21

5.3.1 AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

5.4 Andramed GmbH Company Overview 24

5.4.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Atrium Medical Corporation Company Overview 25

5.5.1 Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Bolton Medical, Inc. Company Overview 26

5.6.1 Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Boston Scientific Corporation Company Overview 29

5.7.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Cordis Corporation Company Overview 32

5.8.1 Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 32

5.9 Hatch Medical, L.L.C. Company Overview 34

5.9.1 Hatch Medical, L.L.C. Pipeline Products & Ongoing Clinical Trials Overview 34

5.10 Innovia LLC Company Overview 35

5.10.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 Lithotech Medical Ltd. Company Overview 36

5.11.1 Lithotech Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 M.A. Med Alliance SA Company Overview 37

5.12.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 37

5.13 Medinol Ltd. Company Overview 38

5.13.1 Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38

5.14 Medtronic plc Company Overview 40

5.14.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40

5.15 Meril Life Sciences Pvt. Ltd. Company Overview 42

5.15.1 Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 42

5.16 MicroPort Scientific Corporation Company Overview 44

5.16.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 44

5.17 Natec Medical Ltd Company Overview 47

5.17.1 Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 Pressure Products, Inc. Company Overview 48

5.18.1 Pressure Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

5.19 QT Vascular Ltd. Company Overview 49

5.19.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49

5.20 QualiMed Innovative Medizinprodukte GmbH Company Overview 55

5.20.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 55

5.21 Revma, Inc. Company Overview 56

5.21.1 Revma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

5.22 The Spectranetics Corporation Company Overview 57

5.22.1 The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 57

5.23 TissueGen, Inc. Company Overview 59

5.23.1 TissueGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

5.24 VasoTech Inc. Company Overview 61

5.24.1 VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

6 Peripheral Transluminal Coronary Angioplasty Balloons- Recent Developments 62

6.1 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 62

6.2 Aug 30, 2016: MPSC Announces 2016 Interim Results 63

6.3 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 64

6.4 Aug 22, 2016: Replacement of President & CEO Getinge Group:Joacim Lindoff appointed Acting President & CEO of Getinge Group 66

6.5 Aug 22, 2016: Joacim Lindoff appointed Acting President & CEO of Getinge Group 67

6.6 Aug 10, 2016: Spectranetics Receives CE Mark for AngioSculptX 67

6.7 Aug 09, 2016: Neovasc Reports Second Quarter Results for 2016 67

6.8 Jul 28, 2016: Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million 70

6.9 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 71

6.10 Jul 26, 2016: Edwards Lifesciences Reports Second Quarter Results 72

6.11 Jul 25, 2016: QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment 74

6.12 Jul 21, 2016: Firefighter PTCA Balloon Dilatation Catheter Granted CE Mark 74

6.13 Jul 21, 2016: Federal Circuit Court Rules in Appeal 75

6.14 Jul 14, 2016: Getinge Interim Report January-June 2016 75

6.15 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 75

6.16 Jul 05, 2016: Neovasc Receives NASDAQ Notification Regarding Minimum Bid Requirements 76

6.17 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 76

6.18 Jun 27, 2016: QT Vascular Receives FDA 510(k) Clearance For Chocolate XD, A Novel PTCA Balloon 77

6.19 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 77

6.20 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 78

6.21 Jun 03, 2016: Getinge Group appoints Jens Viebke as new President of Acute Care Therapies Business Category Unit 78

6.22 Jun 03, 2016: LEPUCARE established in India 79

6.23 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 79

6.24 Apr 01, 2016: MicroPort and Yizheng Municipal Government Establishes "Shanghai-Yizheng Healthcare Cooperation Project" 82

6.25 Mar 29, 2016: Getinge Group Receives Innovative Technology Designation from Novation for the Maquet InterValve V8 Balloon Aortic Valvuloplasty Catheter 82

6.26 Mar 23, 2016: MicroPort Signs Cooperation Agreement with Beijing Weimai Medical Device 83

6.27 Feb 29, 2016: FOXTROT PRO Gains Market Approval in Indonesia 83

6.28 Feb 25, 2016: Spectranetics Achieves Fourth Quarter 2015 Revenue of $65.2 Million 83

6.29 Feb 23, 2016: Lepu Medical Amends Private Placement of Shares for USD110 Million 84

6.30 Feb 11, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore 84

6.31 Feb 10, 2016: QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore 85

6.32 Feb 01, 2016: TE Connectivity to Acquire Creganna Medical from Permira Advisers for USD895 Million 85

6.33 Jan 21, 2016: NC Tadpole Obtained CFDA Registration Certificate 86

6.34 Jan 05, 2016: QT Vascular Announces Clinical Outcomes of Its Chocolate Heart Drug Coated Coronary Balloon 86

6.35 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved 87

6.36 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment 87

6.37 Dec 17, 2015: OrbusNeich demonstrates Sapphire II Coronary Dilatation Catheter at GulfPCR-GIM 2015 88

6.38 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference 88

6.39 Nov 26, 2015: Two Subsidiaries of MicroPort Recognized as One of Shanghai's the First Group of High-tech Enterprise 90

6.40 Nov 18, 2015: Major Expansion for Creganna Medical, Minnesota 90

6.41 Oct 28, 2015: CITIC Private Equity Funds Management to Acquire Biosensors International 91

7 Appendix 92

7.1 Methodology 92

7.2 About GlobalData 94

7.3 Contact Us 94

7.4 Disclaimer 95

1.2 List of Figures

Figure 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9

Figure 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10

Figure 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11

Figure 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12

Figure 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13

Figure 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14

1.1 List of Tables

Table 1: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 9

Table 2: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Segment 10

Table 3: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Territory 11

Table 4: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Regulatory Path 12

Table 5: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Estimated Approval Date 13

Table 6: Peripheral Transluminal Coronary Angioplasty Balloons - Ongoing Clinical Trials 14

Table 7: Peripheral Transluminal Coronary Angioplasty Balloons Companies - Pipeline Products by Stage of Development 15

Table 8: Peripheral Transluminal Coronary Angioplasty Balloons - Pipeline Products by Stage of Development 17

Table 9: Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 19

Table 10: VIAR - Product Status 19

Table 11: VIAR - Product Description 19

Table 12: Acrostak (Schweiz) AG Pipeline Products & Ongoing Clinical Trials Overview 20

Table 13: PTCA Balloon - Product Status 20

Table 14: PTCA Balloon - Product Description 20

Table 15: AlviMedica Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 21

Table 16: Pegaso Aria - Product Status 21

Table 17: Pegaso Aria - Product Description 22

Table 18: Pegaso Brio - Product Status 22

Table 19: Pegaso Brio - Product Description 22

Table 20: ProHP - Product Status 23

Table 21: ProHP - Product Description 23

Table 22: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview 24

Table 23: Zero-Profile PTCA Balloon - Product Status 24

Table 24: Zero-Profile PTCA Balloon - Product Description 24

Table 25: Atrium Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 25

Table 26: Coronary Stent Balloon Catheter - Product Status 25

Table 27: Coronary Stent Balloon Catheter - Product Description 25

Table 28: Bolton Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26

Table 29: Flash PTCA - Product Status 26

Table 30: Flash PTCA - Product Description 26

Table 31: Runner PTCA Balloon Catheter - Product Status 27

Table 32: Runner PTCA Balloon Catheter - Product Description 27

Table 33: Runner Slim PTCA - Product Status 28

Table 34: Runner Slim PTCA - Product Description 28

Table 35: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29

Table 36: 1.2 Zulu PTCA - Product Status 29

Table 37: 1.2 Zulu PTCA - Product Description 30

Table 38: NC Zulu PTCA Post-Dilatation Catheter - Product Status 30

Table 39: NC Zulu PTCA Post-Dilatation Catheter - Product Description 30

Table 40: Zulu PTCA Pre-Dilatation Catheter - Product Status 31

Table 41: Zulu PTCA Pre-Dilatation Catheter - Product Description 31

Table 42: Cordis Corporation Pipeline Products & Ongoing Clinical Trials Overview 32

Table 43: Next Generation EMPIRA PTCA Balloon - Product Status 32

Table 44: Next Generation EMPIRA PTCA Balloon - Product Description 33

Table 45: Hatch Medical, L.L.C. Pipeline Products & Ongoing Clinical Trials Overview 34

Table 46: Hydra Bifurcated Coronary Balloon Catheter - Product Status 34

Table 47: Hydra Bifurcated Coronary Balloon Catheter - Product Description 34

Table 48: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 35

Table 49: Low Profile Angioplasty Balloon Catheter - Product Status 35

Table 50: Low Profile Angioplasty Balloon Catheter - Product Description 35

Table 51: Lithotech Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36

Table 52: Scoring Balloon - Product Status 36

Table 53: Scoring Balloon - Product Description 36

Table 54: M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview 37

Table 55: SELUTION Sirolimus Coated Balloon - Product Status 37

Table 56: SELUTION Sirolimus Coated Balloon - Product Description 37

Table 57: Medinol Ltd. Pipeline Products & Ongoing Clinical Trials Overview 38

Table 58: Gallant PTCA Balloon Catheter - Product Status 38

Table 59: Gallant PTCA Balloon Catheter - Product Description 39

Table 60: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 40

Table 61: Euphora Drug Coated Balloon - Product Status 40

Table 62: Euphora Drug Coated Balloon - Product Description 41

Table 63: Meril Life Sciences Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 42

Table 64: Mozec-Rx PTCA Balloon Dilatation Catheter - Product Status 42

Table 65: Mozec-Rx PTCA Balloon Dilatation Catheter - Product Description 43

Table 66: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 44

Table 67: Hercules-D - Product Status 44

Table 68: Hercules-D - Product Description 45

Table 69: Ryfle PTCA Balloon - Product Status 45

Table 70: Ryfle PTCA Balloon - Product Description 45

Table 71: Ryfle PTCA Balloon Catheter - Product Status 46

Table 72: Ryfle PTCA Balloon Catheter - Product Description 46

Table 73: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Table 74: NATEC Angioplasty Balloon - Product Status 47

Table 75: NATEC Angioplasty Balloon - Product Description 47

Table 76: Pressure Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48

Table 77: SafeVue Balloon Catheter - Product Status 48

Table 78: SafeVue Balloon Catheter - Product Description 48

Table 79: QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview 49

Table 80: Chocolate Heart - Product Status 49

Table 81: Chocolate Heart - Product Description 50

Table 82: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Status 50

Table 83: Chocolate Touch PTCA Coronary Drug Coated Balloon - Product Description 50

Table 84: Silk PTCA Balloon Catheter - Product Status 51

Table 85: Silk PTCA Balloon Catheter - Product Description 51

Table 86: QT Vascular Ltd. - Ongoing Clinical Trials Overview 52

Table 87: Chocolate Touch PTCA Coronary Drug Coated Balloon - Clinical Study Evaluating the Chocolate Touch PTCA Coronary Drug-coated Balloon 53

Table 88: Chocolate Heart - A Feasibility Study of Chocolate Heart Drug Coated Coronary Balloon in De novo Lesions 54

Table 89: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview 55

Table 90: Biodegradable Balloon - Product Status 55

Table 91: Biodegradable Balloon - Product Description 55

Table 92: Revma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56

Table 93: Coronary Post-Dilatation Catheter - Product Status 56

Table 94: Coronary Post-Dilatation Catheter - Product Description 56

Table 95: The Spectranetics Corporation Pipeline Products & Ongoing Clinical Trials Overview 57

Table 96: CardioSculpt Valvuloplasty Scoring Balloon - Product Status 57

Table 97: CardioSculpt Valvuloplasty Scoring Balloon - Product Description 58

Table 98: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Status 58

Table 99: Drug Coated Balloon - In-stent Restenosis (ISR) - Product Description 58

Table 100: TissueGen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59

Table 101: Anti-arrhythmia OTW Device - Product Status 59

Table 102: Anti-arrhythmia OTW Device - Product Description 60

Table 103: VasoTech Inc. Pipeline Products & Ongoing Clinical Trials Overview 61

Table 104: DirectBalloon - Product Status 61

Table 105: DirectBalloon - Product Description 61

Table 106: Glossary 93

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Aachen Resonance GmbH

Acrostak (Schweiz) AG

AlviMedica Medical Technologies Inc.

Andramed GmbH

Atrium Medical Corporation

Bolton Medical, Inc.

Boston Scientific Corporation

Cordis Corporation

Hatch Medical, L.L.C.

Innovia LLC

Lithotech Medical Ltd.

M.A. Med Alliance SA

Medinol Ltd.

Medtronic plc

Meril Life Sciences Pvt. Ltd.

MicroPort Scientific Corporation

Natec Medical Ltd

Pressure Products, Inc.

QT Vascular Ltd.

QualiMed Innovative Medizinprodukte GmbH

Revma, Inc.

The Spectranetics Corporation

TissueGen, Inc.

VasoTech Inc.

select a license
Single User License
USD 4000 INR 289480
Site License
USD 8000 INR 578960
Corporate User License
USD 12000 INR 868440

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com